Long-term follow-up for people who received gene therapy
Part of Cancer, Infections clinical trials.
This study follows people for many years after they receive gene therapy (a treatment that uses lab-made genetic material). It mainly checks long-term safety and health outcomes and may help doctors understand how gene therapy works over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You (or your legal representative) must be able to sign informed consent for this long-term follow-up.
- You must have received gene therapy through a study at MD Anderson.
- You must agree to follow the long-term follow-up period, up to 15 years after treatment.
- You must allow MD Anderson (or a designated NIH facility) to collect and store your medical samples.
- Your original gene therapy study must be approved at MD Anderson.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people long-term after receiving a specific gene-cell treatment called AGT103-T. It helps researchers check long-term safety and outcomes, which can guide future care for others.
This study checks how people do long-term after stem cell transplant, cellular therapy, or gene therapy. It may help doctors track longer-term health effects and recovery and improve future care.
This study checks your health over time after you previously received gene-modified cell therapy in a Sorrento-sponsored trial. It helps researchers understand long-term safety and outcomes and may lead to better care for future patients.
This study checks long-term health after receiving a gene-modified cell therapy through a St. Jude study. It helps doctors understand the treatment’s lasting effects and safety over time.
This study is a long-term follow-up for people who already received gene therapy for sickle cell disease in a specific sponsor’s clinical trial. It helps researchers watch for long-term safety and outcomes over time.
This study follows patients who received gene therapy at Seattle Children's Hospital to check on their health and safety over time. It helps doctors understand how well the treatment works in the long run.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.